Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,956 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for
Alopecia Areata
Location: Dallas TX, Arlington TX, Cedar Park TX, Bellaire TX,
Sponsor: AbbVie

Sex: All

Age: 12 - 63

Code: NCT06012240

Phase 3, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

for
Schizophrenia
Location: Richardson TX, Austin TX, Little Rock AR,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07145918

Phase 2, Recruiting
Featured

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Dallas TX, DeSoto TX, Mansfield TX, Waxahachie TX,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting
Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Dallas TX, Norman OK, Oklahoma City OK, Tulsa OK,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase 3, Recruiting
Featured

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Dallas TX, Mesquite TX, Longview TX, Round Rock TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

for
Atherosclerosis
Location: Dallas TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07448038

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma

for
Primary Open Angle Glaucoma
Location: Dallas TX, Oklahoma City OK, Houston TX, New Orleans LA,
Sponsor: AbbVie

Sex: All

Age: 45+

Code: NCT06822738

Phase 3, Recruiting
Featured

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

for
Diabetic Retinopathy
Location: Dallas TX, Burleson TX, Austin TX, Bellaire TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07592273

Phase 2, Phase 3, Recruiting
Featured

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

for
Alzheimer's Disease
Location: Dallas TX, Cordova TN, Boulder CO, Lady Lake FL,
Sponsor: AbbVie

Sex: All

Age: 50 - 70+

Code: NCT07599670

Phase 1, Phase 2, Recruiting
Featured

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

for
Alzheimers Disease
Location: Dallas TX, Fort Worth TX, Katy TX, Houston TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07177352

Phase 3, Recruiting
Featured

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

for
Muscular Atrophy, Spinal
Location: Dallas TX, Fort Worth TX, Little Rock AR, Aurora CO,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0 - 2

Code: NCT05861986

Phase 4, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: Dallas TX, Fort Worth TX, Tyler TX, Abilene TX,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07059845

Phase 2, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Dallas TX, Fort Worth TX, Tyler TX, Kingwood TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase 3, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Dallas TX, Charlotte NC, Ann Arbor MI,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06953960

Phase 1, Phase 2, Recruiting
Featured

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

for
Ulcerative Colitis
Location: Dallas TX, Atlanta GA, Chicago IL, Greenville SC,
Sponsor: AbbVie

Sex: All

Age: 2 - 17

Code: NCT07071519

Phase 3, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

for
Multiple Myeloma
Location: Dallas TX, Denver CO, Atlanta GA, Cincinnati OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06892522

Phase 1, Phase 2, Recruiting
Featured

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Dallas TX, Nashville TN, Atlanta GA, Valhalla NY,
Sponsor: AbbVie

Sex: All

Age: 0 - 17

Code: NCT07306832

Phase 1, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Dallas TX, Round Rock TX, Tulsa OK, Kansas City KS,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting
Featured

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Tyler TX, Shreveport LA, Austin TX,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting
Featured

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for
HER2-positive Breast Cancer
Location: Fort Worth TX, Austin TX, Germantown TN, Huntsville AL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting